Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
about
Screening for prostate cancerScreening for prostate cancerPSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UKProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisProstate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging rolesQuantification of length-bias in screening trials with covariate-dependent test sensitivity.Sensitivity study and optimization of a 3D electric impedance tomography prostate probeThe PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative studyHigh spectral and spatial resolution MRI of age-related changes in murine prostate.Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008.The discovery of compounds that stimulate the activity of kallikrein-related peptidase 3 (KLK3).What happens after an elevated PSA test: the experience of 13,591 veterans.Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.Pharmacogenetics in clinical practice: considerations for testing.Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative studyQuantifying the role of PSA screening in the US prostate cancer mortality decline.Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales.Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.Should men with serum prostate-specific antigen < or =4 ng/ml and normal digital rectal examination undergo a prostate biopsy? A literature review.The kallikrein world: an update on the human tissue kallikreins.Prostate-specific antigen screening and mortality from prostate cancerUrological referral of asymptomatic men in general practice in EnglandOverdiagnosis and overtreatment of early detected prostate cancer.Survival from prostate cancer in England and Wales up to 2001.Assessment of causes of death in a prostate cancer screening trial.Economic evaluation of prostate cancer screening with prostate-specific antigen.Use of Biomarkers in Screening for Cancer.Prostate specific antigen for early detection of prostate cancer: longitudinal study.Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004.Lead time associated with screening for prostate cancer.The Spanish contribution to the European Randomized Study of Screening for Prostate Cancer.Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial.Geographical variation in incidence of prostate cancer in Sweden.Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?The Finnish trial of prostate cancer screening: where are we now?Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.
P2860
Q24201690-B24CCE70-E151-4E78-AEA1-0D6F292D5664Q24245476-467B41FB-6B30-4366-B190-3A237C692791Q24814107-5872747E-5397-4095-8B38-7B72B4CFD544Q26781093-FBC7F449-728A-42DB-9662-A3BCD6FF9B07Q26865810-02E43592-3655-4BF8-B7C4-BE22A7C7C649Q30299933-33D2B6FE-F47D-419B-B554-9117C7909A0CQ30481197-996DFEB0-E72B-41F0-9827-73EFEE6A2F6EQ33288928-A9828E8F-3771-4EB3-8112-8466A70AEEF6Q33363375-D9AE5E59-E734-4EE0-A895-C745A47C111DQ33750580-89F18A96-D7F1-423F-BDD8-A21DC5A26AD4Q33935048-7D0EDF74-B1F0-4241-BAD0-F5F167569F6DQ34033411-BCD83DCB-540D-4D0C-AE1E-EAC7D9B071CDQ34164258-90E30FB9-9C50-4300-9D6B-9D3AC038C4BFQ34283636-5D69D2AA-7AD9-447D-89CB-1084BB8BF741Q34499056-A3B63B1B-4CF7-40C0-A95E-77156C713D4AQ34514912-33C413B0-B72F-4AB1-BFDD-620641739BB2Q34720042-F75EDB10-39EE-45B1-A7CC-9A9872716863Q36103672-B96D5980-761B-47E8-B1D4-FA93B883B835Q36177334-6BB2837E-DF63-4E7C-9007-C1930B856D8FQ36443076-5B3D1A80-09D1-41A8-B0D5-2C173190C87EQ36519354-7D5978D0-C3F2-4DA5-963D-4F3321195753Q36608116-D1F78BCB-174B-4D2B-B1E2-8B848713DE17Q36608520-8E67D745-9471-4648-A5D8-676215CAE241Q36761279-4ABF8C52-240C-436C-8744-F5C32F90828DQ36917880-43889534-7C9B-4D09-A34E-2A9203AD84DFQ36970410-DD4DEA16-D297-4309-8775-B5DA500456E2Q37124961-CA38AAAC-1338-4B2A-8F74-3573EBB6539EQ37155019-14089E88-3D4C-41D5-95E0-36FE47651B5AQ37362535-2C823CB8-08EA-4825-A375-3D7413806DDFQ37384669-0EB8692F-829D-4D32-8D58-EA22A1825852Q37396566-EBDFB726-A5B2-4F3C-AD98-22804D133A19Q39669271-CD5D6A44-AA42-4385-9A09-9891F4127AC7Q39677083-C682971C-7BD1-4107-BC02-5B8D8670EF7CQ39691732-38CDACB5-6629-46DA-839B-110D2311E6A0Q39734785-B8B0373B-2D6A-453F-A772-0154536CC83CQ39781202-736CD7FD-BEDA-4CFA-A264-58ADD8CE7C42Q40395964-B20E4C12-3DE4-4595-A438-25A592A18569Q41548112-2B8C17C2-79A0-4126-A1B8-CBF1DA026406Q43484941-23AE0722-7EAA-46B1-91BE-CED9051A463AQ45216796-81F91557-A5B9-433E-8BE6-117024977F43
P2860
Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@en
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@nl
type
label
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@en
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@nl
prefLabel
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@en
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@nl
P2093
P2860
P356
P1476
Large-scale randomized prostat ...... rectal and Ovary cancer trial.
@en
P2093
Antonio Berenguer Sanchez
European Randomized Screening for Prostate Cancer (ERSPC) Trial
Fernando Calais da Silva
Fritz H Schröder
Harry J de Koning
International Prostate Cancer Screening Trials Evaluation Group
John K Gohagan
Jonas Hugosson
Louis Denis
Matti Hakama
P2860
P304
P356
10.1002/IJC.1588
P577
2002-01-01T00:00:00Z